Boundless Bio, Inc.BOLDNASDAQ
Loading
Year-over-year SG&A expense growth
Percentile
P12
Within normal range
vs 5Y Ago
-0.3x
Contraction
Streak
1 qtr
Consecutive growthRecovering
| Period | Value |
|---|---|
| Q4 2025 | -6.46% |
| Q3 2025 | -7.60% |
| Q2 2025 | -6.92% |
| Q1 2025 | 4.81% |
| Q4 2024 | 7.31% |
| Q3 2024 | -0.64% |
| Q2 2024 | 24.03% |
| Q1 2024 | 11.00% |
| Q4 2023 | 2.24% |
| Q3 2023 | 14.66% |
| Q2 2023 | 11.65% |
| Q1 2023 | 7.00% |
| Q4 2022 | -3.25% |
| Q3 2022 | 0.00% |
| Q3 2019 | 4.20% |
| Q2 2019 | -18.47% |
| Q1 2019 | 27.79% |
| Q4 2018 | 20.06% |
| Q3 2018 | 24.45% |
| Q2 2018 | -3.65% |
| Q1 2018 | 25.12% |
| Q4 2017 | 19.99% |
| Q3 2017 | 6.81% |
| Q2 2017 | 11.13% |
| Q1 2017 | 13.15% |
| Q4 2016 | 9.89% |
| Q3 2016 | 0.00% |